Trial intelligence / Profile preview

IgPro20 (Hizentra) in Primary Immunodeficiency

NCT00542997Phase 3Completed

Sponsor
CSL Limited
Start
Sep 2007
Primary completion
Aug 2009
Modality
Biologic
Countries
9
01

Overview

A Phase 3 trial of IgPro10 in primary immunodeficiency (PI), sponsored by CSL Limited. Started Sep 2007; status: completed.

02

Drugs

IgPro10
03

Conditions

primary immunodeficiency (PI)

Beyond the preview

Go deeper on NCT00542997.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00542997.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call